摘要
目的在头孢硫脒(A组)、头孢呋辛钠(B组)和头孢地嗪钠(C组)中寻找治疗儿童支气管肺炎的最佳治疗方案。方法采用回顾性研究,对A组与B组和C组治疗儿童支气管肺炎的方案进行成本-效果分析,同时做了敏感性分析。结果C组有效率最高(98.85%),有效率达100%时所需追加的费用最低。结论头孢地嗪钠治疗儿童支气管肺炎,符合药物经济学原则。
Objective To select a best therapeutic regime ns for children＇s bronchopneumonia from three kinds of antibiotics：Cephathiamidin, Cefuroxime Sodium and Cefodizime Sodium. Methods The cost-effectiveness analysis （CEA） of various therapeutic regimens were carried out by retrospective study, meanwhile, three kinds of drug sensitivity test were analyzed. Results The total effective rate （98.85%） of Cefodizime Sodium group was the highest. The additional cost was the lowest when its total effective rate reached to 100%. Conclusions It was remunerative to select Cefodizime Sodium serving as treatment prescription of bronchopneumonia in children than others.
出处
《实用全科医学》
2006年第6期725-726,共2页
Applied Journal Of General Practice
关键词
头孢硫脒
头孢呋辛钠
头孢地嗪钠
支气管肺炎
成本-效果分析
Cephathiamidin
Cefuroxime sodium
Cefodizime Sodium
Bronchopneumonia
Cost-effectiveness analysis
